Teva Pharmaceuticals Industries Ltd. sales and marketing update

Teva launched in the U.S. a generic version of Xeloda capecitabine from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) for metastatic colorectal and breast cancer. The product was the first generi...